Download as doc
Download as doc
You are on page 1of 2

ROSIGLITAZONE

Introduction:

Rosiglitazone is an anti-diabetic drug in the thiazolidinedione


class of drugs. Apart from its effect on insulin resistance, it appears
to have an anti-inflammatory effect: The medication might also be
effective in the treatment of mild to moderate Ulcerative Colitis,
due to its antiinflammatory properties as a PPAR ligand.

Chemical Structure

Chemical name: 5-[4-(2-[methyl(pyridin-2-yl)amino] ethoxy)

benzyl]thiazolidine-2,4-dione.

Chemical Formula: C18H19N3O3S

Molecular Weight: 357.428 g/mol

Drug Description:
Solubility: Slightly soluble in water, Soluble in Ethanol and
DMF.

State:Solid
Melting Point: 122-123 oC
Experimental LogP/Hydrophobicity: 2.4
Protein Binding: 99.8% bound to plasma proteins.
Half Life: 3-4 hours
Mecanism of Action:
Action of rosiglitazone is through activation of the
intracellular receptor class of the peroxisome proliferator-
activated receptors (PPARs), specifically PPARγ. Rosiglitazone is
a selective ligand of PPARγ, and has no PPARα-binding action.

You might also like